Search all trials

Find therapies in clinical trials near you – page 26

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

HER2 positive breast cancer

Recruiting

Registered drugNo placebo

Study on Reducing Treatment for Patients with HER2-Positive Metastatic Breast Cancer Using Trastuzumab and Drug Combination After 2 Years of Controlled Disease

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Pertuzumab

Contact Research Centre

Migraine with aura

Recruiting

Registered drug

Study of Amiloride tablets for prevention of migraine with aura attacks

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Amiloride Hydrochloride Dihydrate

Contact Research Centre

Neuroendocrine carcinoma

Recruiting

Registered drugNo placebo

Study Comparing FOLFIRINOX and Cisplatin-Etoposide for Patients with Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Irritable bowel syndrome

Recruiting

Investigational

Study of Fecal Microbiota Transplantation in Capsule Form Compared to Placebo for Patients with Severe Irritable Bowel Syndrome

Investigational

France

Participants:18–64 years · 65+ years
Substances:Placebo

Contact Research Centre

Mental disorder

Recruiting

Registered drugNo placebo

Study on Rituximab for Patients with Mental Disorders and Autoimmunity

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Rituximab

Contact Research Centre

Cerebral haemorrhage

Recruiting

Registered drugNo placebo

Study on Avoiding Anticoagulation with Apixaban for Patients with Intracerebral Hemorrhage

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Apixaban

Contact Research Centre

Alcohol use disorder

Recruiting

Investigational

Study on Cannabidiol as an Add-On Treatment for Patients with Severe Alcohol Use Disorder During Inpatient Alcohol Cessation

Investigational

France

Participants:18–64 years · 65+ years
Substances:Cannabidiol

Contact Research Centre

Acute lymphocytic leukaemia+1

Recruiting

Registered drugNo placebo

Study on Blinatumomab, Ponatinib, and Isatuximab for Adults Aged 18-65 with Newly Diagnosed Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Blinatumomab

Contact Research Centre

Dermatitis atopic

Not yet recruiting

Registered drug

Efficacy and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Face and Neck Atopic Dermatitis

Registered drug

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lebrikizumab

Contact Research Centre

Dermatitis atopic

Not yet recruiting

Investigational

Testing GIA632 compared to placebo in adults with moderate to severe atopic dermatitis to measure effectiveness and safety

Investigational

France

Participants:18–64 years · 65+ years

Contact Research Centre

Osteoarthritis

Not yet recruiting

Registered drug

Study on the Effects of PPV-06 and Paracetamol for Patients with Inflammatory Knee Osteoarthritis

Registered drug

France

Participants:18–64 years · 65+ years
Substances:His203-Crm197

Contact Research Centre

Study of nemtabrutinib combined with venetoclax and obinutuzumab in untreated CLL/SLL patients with TP53 alterations

Not yet recruiting

Registered drugNo placebo

Study of nemtabrutinib combined with venetoclax and obinutuzumab in untreated CLL/SLL patients with TP53 alterations

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Nemtabrutinib

Contact Research Centre

Find therapies in clinical trials near you – page 26

650 trials match your criteria

HER2 positive breast cancer

Study on Reducing Treatment for Patients with HER2-Positive Metastatic Breast Cancer Using Trastuzumab and Drug Combination After 2 Years of Controlled Disease

Migraine with aura

Study of Amiloride tablets for prevention of migraine with aura attacks

Neuroendocrine carcinoma

Study Comparing FOLFIRINOX and Cisplatin-Etoposide for Patients with Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma

Irritable bowel syndrome

Study of Fecal Microbiota Transplantation in Capsule Form Compared to Placebo for Patients with Severe Irritable Bowel Syndrome

Mental disorder

Study on Rituximab for Patients with Mental Disorders and Autoimmunity

Cerebral haemorrhage

Study on Avoiding Anticoagulation with Apixaban for Patients with Intracerebral Hemorrhage

Alcohol use disorder

Study on Cannabidiol as an Add-On Treatment for Patients with Severe Alcohol Use Disorder During Inpatient Alcohol Cessation

Acute lymphocytic leukaemia+1

Study on Blinatumomab, Ponatinib, and Isatuximab for Adults Aged 18-65 with Newly Diagnosed Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma

Dermatitis atopic

Efficacy and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Face and Neck Atopic Dermatitis

Dermatitis atopic

Testing GIA632 compared to placebo in adults with moderate to severe atopic dermatitis to measure effectiveness and safety

Osteoarthritis

Study on the Effects of PPV-06 and Paracetamol for Patients with Inflammatory Knee Osteoarthritis

Study of nemtabrutinib combined with venetoclax and obinutuzumab in untreated CLL/SLL patients with TP53 alterations

Study of nemtabrutinib combined with venetoclax and obinutuzumab in untreated CLL/SLL patients with TP53 alterations

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.